Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06294886Recruiting

Vaginal Fluid Collection for Detection of Endometrial Cancer

Role: lead

NCT06294873Recruiting

Stool Sample Collection Study

Role: lead

NCT03804593Completed

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Role: collaborator

NCT02512757Completed

A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology

Role: lead

NCT02878928Not ApplicableCompleted

Clinical Study Evaluating Effects of Pharmacogenetic-guided vs Standard-of-Care Treatment on Depression and/or Anxiety

Role: collaborator

All 5 trials loaded